2-(2-oxo-2-phenylethyl)-3,4-dihydronaphthalen-1(2H)-one | 54669-72-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(2-oxo-2-phenylethyl)-3,4-dihydronaphthalen-1(2H)-one
• 英文别名: 2-Phenacyl-1-tetralon；2-Phenacyl-1-tetralone；2-phenacyl-3,4-dihydro-2H-naphthalen-1-one
• CAS: 54669-72-6
• 化学式: C₁₈H₁₆O₂
• 分子量: 264.324
• InChiKey: ITTLQABJFKKHGL-UHFFFAOYSA-N

物化性质

• 熔点：
  80-82 °C
• 沸点：
  160-170 °C(Press: 0.01 Torr)
• 密度：
  1.150±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(2-oxo-2-phenylethyl)-3,4-dihydronaphthalen-1(2H)-one 在 对甲苯磺酸 作用下， 以 氯仿 为溶剂， 以61%的产率得到2-phenyl-4,5-dihydronaphtho[1,2-b]furan
  参考文献：
  名称：

  Stetter, Hermann; Haese, Wilfried, Chemische Berichte, 1984, vol. 117, # 2, p. 682 - 693

  摘要：

  DOI：
• 作为产物：
  描述：

  3',4'-Dihydrospirohept-5-en-2,2'(1'H)-naphthalin>-1'-on 在 3,4-二甲基-5-(2-羟乙基)碘代噻唑 三乙胺 作用下， 以 乙醇 为溶剂， 60.0~550.0 ℃ 、1.33 kPa 条件下， 反应 15.0h， 生成 2-(2-oxo-2-phenylethyl)-3,4-dihydronaphthalen-1(2H)-one
  参考文献：
  名称：

  Stetter, Hermann; Haese, Wilfried, Chemische Berichte, 1984, vol. 117, # 2, p. 682 - 693

  摘要：

  DOI：

文献信息

• Method of treatment with and compositions containing condensed pyrroles
  申请人：American Hoechst Corporation

  公开号：US03931407A1

  公开（公告）日：1976-01-06

  Novel N-phenylpyrroles are disclosed that are effective in the treatment of inflammation and pain in mammals and have the formula ##SPC1## Wherein R is hydrogen, alkyl of one to six carbon atoms, thienyl, phenyl or phenyl substituted by halogen, trifluoromethyl, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkanoylamino of one to six carbon atoms, nitro, cyano, hydroxyl, amino or phenyl; R.sub.1 is carboxyl, alkoxycarbonyl of two to seven carbon atoms, carbamoyl, N-alkylcarbamoyl of two to seven carbon atoms, N,N-dialkylcarbamoyl of three to seven carbon atoms, hydroxycarbamoyl or dialkylphosphinylalkoxycarbonyl of four to 10 carbon atoms; R.sub.2 is hydrogen, hydroxyl, mercapto, halogen, trifluoromethyl, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkylthio of one to six carbon atoms, amino, alkylamino of one to six carbon atoms, dialkylamino of two to six carbon atoms, alkanoylamino of one to six carbon atoms, alkanoylthio of one to six carbon atoms, thiocarbamoyloxy, alkylthiocarbamoyloxy of two to six carbon atoms, dialkylthiocarbamoyloxy of three to seven carbon atoms, carbamoylthio, alkylcarbamoylthio of one to six carbon atoms, dialkylcarbamoylthio of two to seven carbon atoms, carbamoylamino, alkylcarbamoylamino of two to six carbon atoms or dialkylcarbamoylamino of three to seven carbon atoms; R.sub.3 is hydrogen, alkanoyl of one to six carbon atoms, or phenyl; X is alkylene of three to five carbon atoms, alkylene of three to five carbon atoms substituted by alkyl or alkoxy of one to six carbon atoms, divinylene, divinylene substituted by alkyl of one to six carbon atoms, ##SPC2## Wherein D is hydrogen, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkanoylamino of one to six carbon atoms, halogen, amino, nitro or trifluoromethyl; and n is 1 or 2.

  揭示了对哺乳动物的炎症和疼痛治疗有效的新型N-苯基吡咯类化合物，其化学式为##SPC1##其中R为氢、一至六个碳原子的烷基、噻吩基、苯基或被卤素、三氟甲基、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷酰胺基、硝基、氰基、羟基、氨基或苯基取代的苯基；R.sub.1为羧基、二至七个碳原子的烷氧羰基、氨基甲酰基、二至七个碳原子的N-烷基氨基甲酰基、三至七个碳原子的N,N-二烷基氨基甲酰基、羟基氨基甲酰基或四至十个碳原子的二烷氧羰基磷基；R.sub.2为氢、羟基、巯基、卤素、三氟甲基、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷硫基、氨基、一至六个碳原子的烷基氨基、二至六个碳原子的二烷基氨基、一至六个碳原子的烷酰胺基、一至六个碳原子的烷硫酰基、硫代羰氨氧基、二至六个碳原子的烷硫代羰氨氧基、三至七个碳原子的二烷硫代羰氨氧基、硫代羰氨硫基、一至六个碳原子的烷硫代羰氨硫基、二至七个碳原子的二烷硫代羰氨硫基、羰胺基、二至六个碳原子的烷羰胺基或三至七个碳原子的二烷羰胺基；R.sub.3为氢、一至六个碳原子的烷酰基或苯基；X为三至五个碳原子的烷基、被一至六个碳原子的烷基或烷氧基取代的三至五个碳原子的烷基、二烯基、被一至六个碳原子的烷基取代的二烯基，##SPC2##其中D为氢、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷酰胺基、卤素、氨基、硝基或三氟甲基；n为1或2。
• Carboxyarylindoles as nonsteroidal antiinflammatory agents
  作者：V. Brian Anderson、Marc N. Agnew、Richard C. Allen、Jeffrey C. Wilker、Howard B. Lassman、William J. Novick

  DOI：10.1021/jm00224a023

  日期：1976.2

  An extensive series of carboxyarylindoles has been evaluated for antiinflammatory activity in the carrageenin paw edema assay. The requirements for optimal antiinflammatory activity in this series are relatively specific: a central pyrrole nucleus with (a) a 3-carboxy-4-hydroxyphenyl moiety substituted directly on the nitrogen, (b) a 2-phenyl group (R2) with a substituent of low electronegativity,

  已经在角叉菜胶爪水肿试验中评估了一系列羧芳基吲哚的抗炎活性。此系列中最佳抗炎活性的要求是相对特定的：中心吡咯核具有（a）直接在氮上取代的3-羧基-4-羟基苯基部分，（b）具有取代基的2-苯基（R2）低电负性，（c）在3位（R3）上不存在取代基，和（d）在4,5位（X）上稠合的系统，该系统是亲脂的，准平面的，并且不与N发生空间相互作用-苯基。选择了一种衍生物3-（3-羧基-4-羟基苯基）-2-苯基-4,5-二氢-3H-苯并[e]吲哚（42）进行进一步研究。
• Free radical ring expansion and chain extension of 1,3-diketones
  作者：Xue-Jun Mu、Jian-Ping Zou、Zhi-Tao Wang、Wei Zhang

  DOI：10.1016/j.tetlet.2005.05.036

  日期：2005.7

  Free radical-promoted one carbon ring expansion and chain extension of 1,3-diketones including 1,3-diarylpropane-1,3-diones and 2-aroyl-3,4-dihydro-2H-naphalen-1-one to generate corresponding 1,4-diketones are described.

  自由基促进1,3-二酮（包括1,3-二芳基丙烷-1,3-二酮和2-芳酰基-3,4-二氢-2 H-萘-1）的一个碳环扩展和链扩展产生描述了相应的1，4-二酮。
• Cross-coupling of dissimilar ketone enolates via enolonium species to afford non-symmetrical 1,4-diketones
  作者：Keshaba N Parida、Gulab K Pathe、Shimon Maksymenko、Alex M Szpilman

  DOI：10.3762/bjoc.14.84

  日期：——

  Due to their closely matched reactivity, the coupling of two dissimilar ketone enolates to form a 1,4-diketone remains a challenge in organic synthesis. We herein report that umpolung of a ketone trimethylsilyl enol ether (1 equiv) to form a discrete enolonium species, followed by addition of as little as 1.2-1.4 equivalents of a second trimethylsilyl enol ether, provides an attractive solution to

  由于它们紧密匹配的反应性，两个不同的酮烯醇酸酯的偶联形成1，4-二酮仍然是有机合成中的挑战。我们在本文中报道酮三酮甲硅烷基烯醇醚（1当量）的形成形成离散的烯醇，随后加入低至1.2-1.4当量的第二三甲基甲硅烷基烯醇醚，为该问题提供了有吸引力的解决方案。可以使用各种各样的烯醇化物以1％至38％至74％的产率形成1，4-二酮产物。由于使用了两种TMS烯醇醚作为前体，因此交叉偶联的优化应包括研究添加顺序。
• Substituted N-aminoalkylpyrroles
  申请人：American Hoechst Corporation

  公开号：US03997557A1

  公开（公告）日：1976-12-14

  Substituted N-aminoalkylpyrroles of the formula: ##STR1## IN WHICH X, Z, R.sub.1, -R.sub.5 and n are as defined below, and their physiologically tolerable acid addition salts are disclosed to have antiarrhythmic, central nervous system depressant, antiinflammatory and antihypertensive activity. A process for their preparation is also disclosed.

  给出的结果如下：公式为：##STR1## 其中X、Z、R.sub.1、-R.sub.5和n的定义如下，以及它们的生理耐受性酸盐被披露具有抗心律失常、中枢神经系统抑制、抗炎和降压活性。还披露了它们的制备方法。